<table><tr><th>From:</th><th>Ens, Amanda &lt;amanda.ens@baml.com&gt;</th></tr><tr><td>Sent:</td><td>Monday, August 8, 2016 6:42 PM</td></tr><tr><td>To:</td><td>jeevacation@gmail.com</td></tr><tr><td>Subject:</td><td>Physician Dinner with Dr. Yaacov Anziska in NY 8/15</td></tr></table>

Jeffrey, let me know if you’re interested and I’ll try to get a slot.

BofAML biotech analyst Ying Huang is hosting a Physician Dinner with Dr. Yaacov Anziska, M.D, M.S. Assistant Professor in the department of Neurology at SUNY-Downstate Medical Center Program on Monday, August 15th in New York.

Purpose: To discuss treatment of spinal muscular atrophy (SMA). We will discuss latest developments in treatment of SMA with a particular focus on BIIB's Phase 3 trials of nusinersen and the market opportunity for treatment of SMA infants and children.

Host: Ying Huang

Sector Specialist: Dan Lundquist

Corporate Access: Caroline Goodson

Time/Location: 7PM/Midtown location TBA

Format: Group Dinner

Bio:

Yaacov Anziska, M.D, M.S. is Assistant Professor in the department of Neurology at SUNY-Downstate Medical Center. He directs the Muscular Dystrophy Association (MDA) Neuromuscular Clinic and also serves as the Assistant Residency Director in Neurology. Dr. Anziska also has a strong interest in bringing new drugs and treatments from the lab into clinical practice, as well as pursuing the latest genetic testing available in neuromuscular disease. Dr. Anziska treats 12- 15 SMA patients per month and is familiar treatments for SMA in Type 1, 2, and 3 patients including nusinersen.

Amanda Ens

Director

Bank of America Merrill Lynch

Merrill Lynch, Pierce, Fenner & Smith Incorporated

One Bryant Park, 5th Floor, New York, NY 10036

████████████████████████████████████████████████████████████████

The power of global connections™